$63.6 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 6 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 60.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NTP | NAM TAI PPTY INC | $30,466,000 | -32.5% | 7,219,372 | 0.0% | 47.88% | -10.6% | |
LNDC | Buy | LANDEC CORP | $22,347,000 | +222.6% | 2,241,394 | +3.0% | 35.12% | +327.3% |
RENN | New | RENREN INCsponsored ads | $4,238,000 | – | 146,525 | +100.0% | 6.66% | – |
HMTV | New | HEMISPHERE MEDIA GROUP INCcl a | $2,578,000 | – | 337,868 | +100.0% | 4.05% | – |
CCEL | Sell | CRYO-CELL INTL INC | $2,084,000 | -23.5% | 353,210 | -1.1% | 3.28% | +1.3% |
Sell | CBL & ASSOC PPTYS INC | $1,922,000 | -55.4% | 81,810 | -37.6% | 3.02% | -41.0% | |
NOTV | Exit | INOTIV INC | $0 | – | -264,598 | -100.0% | -29.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NAM TAI PPTY INC | 16 | Q3 2022 | 60.5% |
AVID BIOSERVICES INC | 13 | Q4 2021 | 46.6% |
XPEL INC | 10 | Q4 2021 | 22.3% |
TARO PHARMACEUTICALS INDUS LTD | 8 | Q4 2015 | 85.7% |
AMERCO | 8 | Q4 2015 | 11.2% |
NATHANS FAMOUS INC NEW | 7 | Q1 2017 | 68.9% |
MMA CAP MGMT LLC | 7 | Q1 2017 | 17.8% |
CBL & ASSOC PPTYS INC | 6 | Q3 2023 | 95.2% |
LIFECORE BIOMEDICAL INC | 6 | Q4 2022 | 35.1% |
CRYO-CELL INTL INC | 6 | Q4 2022 | 11.0% |
View ISZO CAPITAL MANAGEMENT LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-12 |
View ISZO CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.